You are here

Research Support

To advance scientific knowledge and develop treatments and cures for breast cancer, the Extramural Grants Administration Program staff will issue requests for applications on behalf of the Health Research Science Board. Check this web site for updates, or sign up for HRSB eAlerts and indicate Request for Applications (RFA) as your area of interest.

Click here for tips on managing graphics and file sizes submitted with your RFA or RFP.

Anticipated Funding Opportunity

  • Healthcare Practitioner Breast Cancer Education Research Projects (Round 2) 

Current Funding Opportunities

  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects (Round 6): The purpose of this RFA is to encourage the development and implementation of innovative pilot projects in breast cancer risk reduction education with rigorous evaluation and revision. Successful applications will propose the design of new educational strategies to elicit behavior changes intended to reduce specific risk factors associated with developing breast cancer. The applicant must be a New York State not-for-profit community-based organization (CBO) or an accredited academic institution within New York with authority to confer graduate degrees in medicine, physician assistant, nursing, health education or public health studies. All applicants must enter into a partnership. The partnership must be between an academic institution and a CBO (see RFA for eligibility specifics). Approximately $270,000 is available to support approximately one (1) award from this RFA. The funding is available for a period of up to three years. To learn more about this opportunity, please visit the New York State Grants Gateway (link is external) and search using the keywords, Patricia S. Brown, and select the Department of Health as the Funding Agency. Letters of Intent are strongly encouraged and due by October 16, 2018. Applications are due by 4:00 PM EST on January 3, 2019 in the New York State Grants Gateway. 

  • Peter T. Rowley Breast Cancer Scientific Research Projects (Round 5): This RFA provides funding for researchers to try new methods and approaches in breast cancer research.  These projects are self-contained research projects.  They are not intended to fund smaller components of larger research projects, solely for data collection, for incremental or correlative research aims, or for compression of a larger project into a smaller time frame.  Responsive applications include the following projects: highly speculative, exploratory, or high-risk; may not have preliminary data, but have the potential for high scientific payoff; application or development of state-of-the-art technologies, tools or resources for breast cancer research; innovative or developmental; focus on exceptionally promising topics and have some pilot data, but not yet sufficiently mature to compete successfully for funding for a full-scale study and/or; testing new hypotheses based on research grounded in a non-breast cancer research area. Approximately $2.16 million will be available through this RFA to support approximately five to seven awards. The funding is for a period of two years. To download a copy of the RFA and instructions, visit the New York State Grants Gateway (link is external) and search using the keywords, Peter T. Rowley, and select the Department of Health as the Funding Agency. Letters of Intent are strongly encouraged and due by October 18, 2018. Applications are due by 4:00 PM EST on December 6, 2018 in the New York State Grants Gateway. 

Recent Awards

  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 4). These projects are two-year awards.
Principal Investigator Sponsoring Institution Amount Title

Scott A. Coonrod, Ph.D.

Cornell University $358,832 Histone Citrullination in Estrogen Receptor Signaling and Breast Cancer
Jo L. Feudenheim, Ph.D. University at Buffalo $359,024 The Microbiome in the Etiology and Prevention of Breast Cancer

Jun Lin, M.D., Ph.D.

Stony Brook University $360,000 Effects of Anesthetics on Lung Metastasis in Mouse Models of Breast Cancer
Cristina Montagna, Ph.D. Albert Einstein College of Medicine $360,000 Somatic Mutation Rate in Mammary Epithelial Cells and Peripheral B-Lymphocytes as Risk Factor for Breast Cancer

Harry Ostrer, M.D.

Albert Einstein College of Medicine $326,910 High Throughput Functional Genomics to Guide Precision Care
Jonathan C. Pertruccelli, Ph.D., University at Albany $335,905 A Simultaneous Phase and Scatter Imaging Towards a Clinical System for Early Stage Breast Cancer Diagnosis
Jose Silva, Ph.D. Icahn School of Medicine at Mount Sinai $360,000 Sensing Cell Geometry: A Novel Checkpoint Critical for Breast Tumor Suppression
  • Patricia S. Brown Breast Cancer Risk Reduction Education Research Projects RFA (Round 5). These projects are three-year awards.
Principal Investigator Sponsoring Institution Amount Title
Lina Jandorf, M.A. Icahn School of Medicine at Mount Sinai $268,599 Development of an Intergenerational Breast Health Community Education Program for Black Women: Reducing the Risk for Triple Negative Breast Cancer in Black Women through Breastfeeding
Jin Young Seo, Ph.D. The Research Foundation of CUNY, Hunter College $245,002 A Culturally Tailored Education Program to Reduce Breast Cancer Risk in Korean Immigrant Women
  • Peter T. Rowley Breast Cancer Scientific Research Projects RFA (Round 3). These projects are two-year awards.
Principal Investigator Sponsoring Institution Amount Title
Chia-Hsin Chan, Ph.D. The Research Foundation for SUNY Stony Brook $359,999 A New Strategy and Tool to Tackle Cancer Stem Cells and Metastasis in Triple-negative Breast Cancer

Mikala Egeblad, Ph.D.

Cold Spring Harbor Laboratory $345,800 Modulating Innate-adaptive Immune Cell Interactions for the Immunotherapy of Breast Cancer
Sharon S. Evans, Ph.D. Health Research Incorporated, Roswell Park Cancer Institute $360,000 Novel Mechanism of Immune Subversion by Myeloid-Derived Suppressor Cells in Aggressive Breast Cancer
John G. Frelinger, Ph.D. University of Rochester $357,747 Amplifying Immune Responses to Breast Cancer Using a Novel IL.2 Therapy to Limit Side Effects and Enhance Efficacy
David Jeruzalmi, Ph.D. The Research Foundation of CUNY obo City College of New York $347,200 Laying the Foundation for Combination Therapy Against Breast Cancer: Analysis of Human Shelterin-DNA Complex
Mira Krendel, Ph.D. The Research Foundation for SUNY Upstate Medical University $360,000 Myosin 1e as a Potential Therapeutic Target in Breast Cancer
Juntao Luo, Ph.D. State University of New York Upstate Medical University $360,000 Structure-based Nanocarrier Design for Targeted Cabazitaxel Delivery to the Advanced Breast Cancer Brain Metastases
Mark Noble, Ph.D. University of Rochester $359,907 Safer and More Effective Treatment of Luminal Breast Cancer and Overcoming Tamoxifen Resistance

Scott Powers, Ph.D.

The Research Foundation for SUNY Stony Brook $350,302 Single-cell Barcoding to Study Breast Cancer Evolution and Drug Resistance

Robert J. Schneider, Ph.D.

New York University School of Medicine $360,000 Reversing Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
  • Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA (Round 2): A total of $3,597,800 million in Peter T. Rowley Breast Cancer Research Project and Postdoctoral Fellowship Awards RFA awards were made in 2011, providing initial support for preliminary testing of novel or exploratory hypotheses related to breast cancer. Recipients are expected to open a new area of investigation, satisfactorily test a novel hypothesis, or produce viable data for preparation of a full-scale research application to another organization. Awards were made to eight investigators, with a maximum of $360,000 for two-year projects. 
Principal Investigator Sponsoring Institution Amount  Title
Anne R. Bresnick, Ph.D. Albert Einstein College of Medicine $360,000 Stromal Contribution of the S100A4 Metastasis Factor to Tumor Invasion
Pamela Cowin, Ph.D. New York University School of Medicine $360,000 The Role of Gpr 125 in Breast Development and Cancer
Johanna A. Joyce, Ph.D. Sloan-Kettering Institute for Cancer Research $360,000 Investigating and Targeting Interactions Between Cancer and the Microenvironment in Breast to Brain Metastasis
Paraic A. Kenny, Ph.D. Albert Einstein College of Medicine $360,000 Consequences of GATA3 Mutation for Normal Mammary Gland Development and Breast Cancer
Xiaojing Ma, Ph.D. Weill Cornell Medical College $360,000 Targeting CCL5 in Triple Negative Breast Cancer
Jeffrey W. Pollard, Ph.D. Albert Einstein College of Medicine $360,000 Macrophages and Immunosuppression in Breast Cancer
Elizabeth A. Repasky, Ph.D. Roswell Park Cancer Institute $357,000 Is the Immune Response Against Breast Cancer Inhibited by Lack of Available Metabolic Energy?
Rodney Rothstein, Ph.D. Columbia University $360,000 Developing a New Paradigm to Discover Novel Breast Cancer Drug Targets